Top-News

Growblox Sciences News

Keine aktuellen Kursdaten verfügbar
WKN: A11218
ISIN: US3998471029
Typ: Aktie

Growblox Sciences News

20.12.19 - PR Newswire
GB Sciences Announces Outstanding Results from Preclinical Study of Its Parkinson's Disease Formulations
GB Sciences Announces Outstanding Results from Preclinical Study of Its Parkinson's Disease Formulations PR Newswire
05.12.19 - PR Newswire
GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson's Disease and Neuropathic Pain
GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-​Based Medical Compounds for Parkinson's ...
18.11.19 - PR Newswire
GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master Research and Development Agreement
GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master ...
06.11.19 - PR Newswire
The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed
The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed PR Newswire
31.10.19 - PR Newswire
GB Sciences Welcomes Esteemed Patent and Intellectual Property Attorney, Mr. Edmond DeFrank, to Its Board of Directors
GB Sciences Welcomes Esteemed Patent and Intellectual Property Attorney, Mr. Edmond DeFrank, to Its Board of Directors PR Newswire
09.10.19 - PR Newswire
GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine
GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine PR Newswire
17.09.19 - PR Newswire
GB Sciences Sells Its Louisiana Medical Marijuana Business At A $32 Million Total Valuation
GB Sciences Sells Its Louisiana Medical Marijuana Business At A $32 Million Total Valuation PR Newswire
03.09.19 - PR Newswire
U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-Three Applications to Become a DEA-Registered Cannabis Supplier to U.S. Marijuana Researchers
U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-​Three Applications to Become a DEA-​Registered Cannabis Supplier to U.S. ...
28.08.19 - PR Newswire
GB Sciences Names Darin Carpenter as Executive Vice President of Cannabis Operations
GB Sciences Names Darin Carpenter as Executive Vice President of Cannabis Operations PR Newswire
07.08.19 - PR Newswire
GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists
GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists PR Newswire
06.08.19 - PR Newswire
History Made! GB Sciences Louisiana Announces Medical Cannabis Products Now for Sale for First Time in State History
History Made! GB Sciences Louisiana Announces Medical Cannabis Products Now for Sale for First Time in State History PR Newswire
17.07.19 - PR Newswire
GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-Derived Formulations
GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-​Derived Formulations In the US, chronic pain represents an estimated ...
11.06.19 - PR Newswire
GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients
GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-​Derived Ingredients PR Newswire
28.05.19 - PR Newswire
GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies
GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-​Neuropathic Pain Therapies GBS Global Biopharma's proprietary ...
14.05.19 - PR Newswire
GB Sciences Prepares to Triple Production Capabilities in Its Las Vegas Facility
GB Sciences Prepares to Triple Production Capabilities in Its Las Vegas Facility Positioned to Increase Revenue by Approximately $5.6 Million PR Newswire
16.04.19 - PR Newswire
GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center
GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center Increases production ...
02.04.19 - PR Newswire
Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times
Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on ...
28.03.19 - PR Newswire
GB Sciences Study Shows Nevada's Cannabis Strain Names Have No Correlation to Active Ingredients
GB Sciences Study Shows Nevada's Cannabis Strain Names Have No Correlation to Active Ingredients What consumers see is not what they get: Study finds almost no chemical ...
26.03.19 - PR Newswire
In Case You Missed It: GB Sciences Approved For Full Operations In Main LSU AgCenter Production Facility
In Case You Missed It: GB Sciences Approved For Full Operations In Main LSU AgCenter Production Facility With over five times the production capacity, main facility will allow for a ...
22.03.19 - PR Newswire
Louisiana Agriculture Commissioner Approves GB Sciences To Begin Full Operations In Main LSU AgCenter Production Facility
Louisiana Agriculture Commissioner Approves GB Sciences To Begin Full Operations In Main LSU AgCenter Production Facility With over five times the production capacity, main ...

Newssuche

Videos

newspaper
08:40 Uhr +24,14%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »